NO964910L - Fremgangsmåte og reagenser for behandling av rheumatoid arthritt - Google Patents

Fremgangsmåte og reagenser for behandling av rheumatoid arthritt

Info

Publication number
NO964910L
NO964910L NO964910A NO964910A NO964910L NO 964910 L NO964910 L NO 964910L NO 964910 A NO964910 A NO 964910A NO 964910 A NO964910 A NO 964910A NO 964910 L NO964910 L NO 964910L
Authority
NO
Norway
Prior art keywords
methods
treatment
rheumatoid arthritis
arthritogenic
reagents
Prior art date
Application number
NO964910A
Other languages
English (en)
Other versions
NO964910D0 (no
NO320773B1 (no
Inventor
Dennis A Carson
Albani Salvatore
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO964910L publication Critical patent/NO964910L/no
Publication of NO964910D0 publication Critical patent/NO964910D0/no
Publication of NO320773B1 publication Critical patent/NO320773B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
NO19964910A 1994-05-20 1996-11-19 Isolert polypeptid og vektor omfattende dette, artrittogent peptid av polypeptidet og sammensetning omfattende dette for forebyggelse og behandling av reumatoid artritt. NO320773B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24698894A 1994-05-20 1994-05-20
PCT/US1995/004896 WO1995031984A1 (en) 1994-05-20 1995-04-24 Method and reagents for the treatment of rheumatoid arthritis

Publications (3)

Publication Number Publication Date
NO964910L true NO964910L (no) 1996-11-19
NO964910D0 NO964910D0 (no) 1996-11-19
NO320773B1 NO320773B1 (no) 2006-01-23

Family

ID=22933053

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964910A NO320773B1 (no) 1994-05-20 1996-11-19 Isolert polypeptid og vektor omfattende dette, artrittogent peptid av polypeptidet og sammensetning omfattende dette for forebyggelse og behandling av reumatoid artritt.

Country Status (11)

Country Link
EP (1) EP0762881B1 (no)
JP (1) JPH10500679A (no)
AT (1) ATE261735T1 (no)
AU (1) AU696646B2 (no)
CA (1) CA2188582A1 (no)
DE (1) DE69532714T2 (no)
FI (1) FI964604A (no)
HU (1) HU220101B (no)
NO (1) NO320773B1 (no)
NZ (1) NZ284914A (no)
WO (1) WO1995031984A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094597B1 (en) 1994-05-20 2006-08-22 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
US5773570A (en) * 1994-05-20 1998-06-30 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
US7608683B2 (en) 2000-08-09 2009-10-27 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
IL155610A0 (en) * 2000-11-01 2003-11-23 Univ California Immunomodulatory peptides derived from heat shock proteins and uses thereof
DK1964570T3 (da) 2007-03-02 2012-12-17 Protectimmun Gmbh Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme
DE202007003266U1 (de) 2007-03-02 2008-07-17 Bufe, Albrecht, Prof. Dr. Med. Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen
EP2346512A1 (en) 2008-08-16 2011-07-27 Protectimmun GmbH Composition for prevention and treatment of allergic and/or inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
CA2056450A1 (en) * 1989-05-31 1990-12-01 Dennis A. Carson Method to treat rheumatoid arthritis

Also Published As

Publication number Publication date
HU220101B (hu) 2001-10-28
FI964604A0 (fi) 1996-11-18
AU2360095A (en) 1995-12-18
HUT76359A (en) 1997-08-28
ATE261735T1 (de) 2004-04-15
JPH10500679A (ja) 1998-01-20
FI964604A (fi) 1997-01-15
WO1995031984A1 (en) 1995-11-30
EP0762881A1 (en) 1997-03-19
DE69532714D1 (de) 2004-04-22
DE69532714T2 (de) 2005-03-10
NO964910D0 (no) 1996-11-19
EP0762881B1 (en) 2004-03-17
HU9603214D0 (en) 1997-01-28
AU696646B2 (en) 1998-09-17
NO320773B1 (no) 2006-01-23
EP0762881A4 (en) 1999-05-06
CA2188582A1 (en) 1995-11-30
NZ284914A (en) 2000-08-25
MX9605692A (es) 1998-05-31

Similar Documents

Publication Publication Date Title
EP0713530A4 (en) HIGH-LEVEL EXPRESSION, PURIFICATION AND FOLDING OF GROUP B PORINE PROTEINS FROM NEISSERIA MENINGITIDIS EXTERNAL MEMBRANE
NO970532D0 (no) System og metode for blodbehandling
CA2212058A1 (en) Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease
ATE210323T1 (de) Erkennungssystem zum erkennen von personen
DE69432582D1 (de) System zur Administration von Flüssigkeiten bei mehreren Patienten
DE69612411D1 (de) Unterwasserbehandlungsverfahren und -system
BR9609395A (pt) Processos e aparelho de processamento de sangue extracorpóreo
FR2734147B1 (fr) Dispositif d'osteosynthese implantable
OA07291A (fr) Gilet orthopédique de soutien et de contention dans le traitement des traumatisés et des opérés de l'épaule, de la ceinture scapulaire et du membre supérieur.
DE69422997D1 (de) Blutsauerstoffsystem und herstellverfahren
GB9417913D0 (en) Odour sensor
DE69424640D1 (de) Filmbehandlungsmethode und System
NO970535D0 (no) Behandlingssystem for avgitt blod og metode for å danne regulerte virvelströmforhold
FR2736535B3 (fr) Dispositif d'osteosynthese rachidienne
NO964910D0 (no) Fremgangsmåte og reagenser for behandling av rheumatoid arthritt
FR2687561B1 (fr) Dispositif de redressement, de fixation, de compression et d'elongation de vertebres cervicales.
CZ2000806A3 (cs) Demonstrační zařízení ve tvaru živého tvora
DE69624243D1 (de) Verwendung von unverdaulichen oligosacchariden zur vorbeugung und behandlung von mittelohrentzündung bei menschen
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ITMI922255A0 (it) Metodo perfezionato per la realizzazione di titoli di credito in genere e dispositivo per un corretto riconoscimento della titolarita' degli stessi.
ITBZ930024A0 (it) Metodo per la rilevazione di movimenti discontinui irregolaridi una persona e impianto per la sua attuazione.
DE69634879D1 (de) Zuckerketten-erkennender antikörper sowie mittelgegen eine hiv-infektion
IL122426A0 (en) Method of identifying persons susceptible to neuropsychiatric disorders
ITMO920002A0 (it) -strumenti e loro metodo di utilizzazione per l'insegnamento di tecniche medico chirurgiche e infermieristiche.
RU93006338A (ru) Устройство для вытяжения позвоночника